02/13/2020
Congratulations to OncoImmunin, Inc. for issuance of U.S. Patent #10,557,136 entitled “In vivo delivery of oligonucleotides
Biotechnology company Biotechnology company with unique, patented delivery technology for peptides and oligonucleotides
207A Perry Pkwy, Ste 6
Gaithersburg, MD
20877
Be the first to know and let us send you an email when OncoImmunin, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to OncoImmunin, Inc.: